Karen Yelsits

Dynamic Specialty Sales Leader with experience across cardiovascular, respiratory, and surgical therapies in both device and pharmaceutical settings. Proven track record driving formulary access, accelerating product adoption, and building strong provider relationships across academic and community settings. Recognized for delivering clinical education and navigating complex hospital systems, to support adoption of specialty therapies that improve patient outcomes and quality of life.

RESPIRATORY SALES SPECIALIST - Syneos Health / AstraZeneca - Boston North

(2025-04 - 2025-12)

Therapeutic areas: Respiratory (Airsupra, Breztri) Specialty Care

• Revitalized a vacant respiratory specialty territory, quickly establishing key customer relationships and driving early growth.
• Drove business across allergy and pulmonary accounts supporting asthma and COPD management.
• Led and mentored two newly hired representatives, providing territory strategy, physician insights, and guidance on navigating high value accounts while independently managing the territory for 4 months.
• Achieved measurable sales growth- increased sales by 30% with proper planning of P1&P2 HCPs for Breztri and Ultra & P1 HCPs for Airsupra.

BURN CENTER BUSINESS MANAGER - Mallinckrodt Pharmaceuticals - Northeast Region

(2023-09 - 2024-01)

• Launched and promoted StrataGraft, a regenerative biologic therapy, to burn centers, plastic/reconstructive surgeons, and hospital wound/trauma teams.
• Drove early formulary and clinical adoption through education with pharmacy, P&T committees, and surgical departments.
• Increased sales by 25% after product launch.

SURGICAL DEVICE SPECIALIST - Innocoll Biotherapeutics (Pharmaceutical & Surgical Portfolio; Partner: Ethicon Hernia) - Boston, MA

(2021-06 - 2023-01)

Sold a unique non-opioid collagen implant, Xaracoll (bupivacaine HCL), to general surgeons for post-operative pain management following open inguinal hernia repair; portfolio included hernia mesh and fixation devices.

• Ranked Top 25% (19/80) in sales H2 2022
• Finished ranked top 30% (24/80) in total sales for 2022 YTD
• Achieved formulary approval and adoption at Landmark Medical Center, becoming the first hospital in New England for approval. I was the second representative company-wide (out of 48 Prime Healthcare accounts) for this formulary win.
• Expanded hospital buy-in and implementation at BI Deaconess Medical Center and Roger Williams Hospital, with Brigham and Women's Hospital under review prior to company closure.

TERRITORY MANAGER - ACell, Inc. - Boston North

(2020-01 - 2021-01)

ACell, a leading regenerative medicine device start-up company. Sold MatriStem UBM (Urinary Bladder Matrix ) devices for acute and chronic wounds with Cytal and MicroMatrix and Gentrix for soft-tissue reinforcement.

• New to market/territory product launch
• Exceeded quota, finishing November at 111% during pandemic

FIELD CLINICAL SPECIALIST II - Edwards Lifesciences - Boston North

(2018-12 - 2019-03)

Supported cardiologists and surgeons in the successful preparation and implantation of transcatheter aortic valve replacement (TAVR) procedures.

• Participated in an intensive hands-on training program, assisting with scrubbing into live cases across major hospital systems in Philadelphia and Atlanta.

TERRITORY SALES MANAGER - Cardiovascular Systems, Inc. (Abbott) - Greater Boston Area

(2017-03 - 2018-08)

Promoted Diamondback 360 Peripheral Orbital Atherectomy System to interventional cardiologists, interventional radiologists, and vascular surgeons for the treatment of severe peripheral arterial disease.

• 4Q2017 at 96.3% to quota
• 3Q2018 at 103% to quota
• Ranked top 10 nationally 4Q2017-1Q2018 for new product sales launch/Cabo contest.
• Provided exceptional support to existing customers, including clinical education / training of medical staff, leading to increased repeat business and referrals.

SALES ACCOUNT MANAGER II - Corindus Vascular Robotics (Siemens) - Boston North

(2015-08 - 2017-03)

Promoted CorPath 200, a robotic-assisted PCI (percutaneous coronary intervention) system to allow interventional cardiologists and cardiac fellows to dramatically reduce radiation exposure during cath lab procedures

• Launched and trained interventional cardiologists and fellows in the Cardiac Cath Lab at MGH and grew the number of certified Robotic users from 0 to 4 at MGH and from 1 to 3 at Buffalo General.
• Increased sales by 25% YOY from driving utilization, new physician users with reduced radiation exposure, precision, and clinical value.
• 114% to Plan Achievement and Account Goals year to date.

ACCOUNT SALES MANAGER - Access Closure Inc. (a Cardinal Health Company) - New England Region

(2012-04 - 2014-08)

Promoted MynxGrip Vascular Closure Device to interventional cardiologists, and interventional radiologists and vascular surgeons in the Boston academic teaching hospitals with surgical case support.

• Key Accomplishments-2012 106% to quota, 2013 98.8% to quota, 2014 101% to quota.

INDEPENDENT PACEMAKER SALES REPRESENTATIVE - Biotronik, Inc - Boston-North

(1998-07 - 2011-01)

Sold Biotronik pacemakers to cardiologists and electrophysiologists in Greater Boston (straight commission) and 24-hour, 7 days a week on-call territory coverage with implant case support.

• Leveraged cardiology relationships and grew and maintained business from ground up.
• Ranked top performer for new growth achievement and increased sales year over year.

Bachelor of Arts - Biology - Merrimack College

Associate Degree - Animal Science - University of New Hampshire